Novel point mutation and intronic mutations of RB1 gene in retinoblastoma patients in Indonesia

  • Batari Todja Umar Department of Ophthalmology, Faculty of Medicine, Universitas Hasanuddin, Makassar, Indonesia https://orcid.org/0000-0002-9734-3215
  • Ulfah Rimayanti Department of Ophthalmology, Faculty of Medicine, Universitas Hasanuddin, Makassar, Indonesia; School of Medicine, Universitas Islam Negeri Alauddin Makassar, Makassar, Indonesia https://orcid.org/0000-0001-9952-5533
  • Halimah Pagarra Department of Ophthalmology, Faculty of Medicine, Universitas Hasanuddin, Makassar, Indonesia
  • Budu Department of Ophthalmology, Faculty of Medicine, Universitas Hasanuddin, Makassar, Indonesia; Graduate School of Universitas Hasanuddin, Universitas Hasanuddin, Makassar, Indonesia
  • Nasrum Massi Department of Microbiology, Faculty of Medicine, Universitas Hasanuddin, Makassar, Indonesia
  • Habibah Setyawati Muhiddin Department of Ophthalmology, Faculty of Medicine, Universitas Hasanuddin, Makassar, Indonesia https://orcid.org/0000-0003-3019-2691
DOI: https://doi.org/10.13181/mji.oa.236544
Keywords: germline mutation, RB1 gene, retinoblastoma
Abstract viewed: 369 times
PDF downloaded: 202 times
HTML downloaded: 58 times
EPUB downloaded: 55 times

Abstract

BACKGROUND Retinoblastoma (RB) is an inherited disorder caused by the RB1 gene mutation in retinal cells or germline mutation. Identifying the specific mutation is crucial for prognosis, inheritance risk assessment, and treatment planning. This study aimed to identify the germline mutation in the RB1 gene in patients with RB and their parents from the eastern part of Indonesia.

METHODS This observational analytic study recruited patients with RB and their parents between 2016 and 2018 at Dr. Wahidin Sudirohusodo Hospital, Makassar, Indonesia. The normal control subjects were children from the outpatient clinic at the Department of Ophthalmology, Universitas Hasanuddin Hospital. Ophthalmic examinations and peripheral blood tests were performed in RB patients, their parents, and control subjects. Genomic DNA was isolated from blood leukocytes and amplified using conventional PCR. Hotspot exons 8, 10, 14, 17, and 22 were screened for mutations using the Sanger method.

RESULTS There were 21 patients with RB (16 unilateral and 5 bilateral) and 14 normal subjects. Of the 184 variations detected in RB patients, 164 were also found in normal subjects. 19 intronic mutations in introns 10, 16, 17, and 21, and 1 novel missense mutation in exon 17 were identified. Parental testing revealed 8 substitutions in exon 17 and 5 intronic mutations in introns 16 and 17 of the parents. None of the variations in exons were passed to their children.

CONCLUSIONS This study found a novel missense mutation in exon 17 of the RB1 gene.

References

  1. Dimaras H, Corson TW. Retinoblastoma, the visible CNS tumor: a review. J Neurosci Res. 2019;97(1):29-44. https://doi.org/10.1002/jnr.24213

  2. Ramasubramanian A, Shields CL. Staging and treatment strategies. In: Ramasubramanian A, Shields CL, editors. Retinoblastoma. New Delhi: Jaypee Brothers Medical Publishers Ltd; 2012. p. 70-8. https://doi.org/10.5005/jp/books/11629_8

  3. Kalsoom S, Wasim M, Afzal S, Shahzad MS, Ramzan S, Awan AR, et al. Alterations in the RB1 gene in Pakistani patients with retinoblastoma using direct sequencing analysis. Mol Vis. 2015;21:1085-92.

  4. Ganguly A, Nichols K. Genetics of retinoblastoma: molecular and clinical aspects. In: Ramasubramanian A, Shields CL, editors. Retinoblastoma. New Delhi: Jaypee Brothers Medical Publishers Ltd; 2012. p. 24-33. https://doi.org/10.5005/jp/books/11629_4

  5. Rogers KT, Higgins PD, Milla MM, Phillips RS, Horowitz JM. DP-2, a heterodimeric partner of E2F: identification and characterization of DP-2 proteins expressed in vivo. Proc Natl Acad Sci U S A. 1996;93(15):7594-9. https://doi.org/10.1073/pnas.93.15.7594

  6. Nguyen HH, Nguyen HTT, Vu NP, Le QT, Pham CM, Huyen TT, et al. Mutational screening of germline RB1 gene in Vietnamese patients with retinoblastoma reveals three novel mutations. Mol Vis. 2018;24:231-8.

  7. Lohmann DR. RB1 gene mutations in retinoblastoma. Hum Mutat. 1999;14(4):283-8. https://doi.org/10.1002/(SICI)1098-1004(199910)14:4<283::AID-HUMU2>3.0.CO;2-J

  8. Kiran VS, Kannabiran C, Chakravarthi K, Vemuganti GK, Honavar SG. Mutational screening of the RB1 gene in Indian patients with retinoblastoma reveals eight novel and several recurrent mutations. Hum Mutat. 2003;22(4):339. https://doi.org/10.1002/humu.9181

  9. Sampieri K, Hadjistilianou T, Mari F, Speciale C, Mencarelli MA, Cetta F, et al. Mutational screening of the RB1 gene in Italian patients with retinoblastoma reveals 11 novel mutations. J Hum Genet. 2006;51(3):209-16. https://doi.org/10.1007/s10038-005-0348-3

  10. Ayari-Jeridi H, Moran K, Chebbi A, Bouguila H, Abbes I, Charradi K, et al. Mutation spectrum of RB1 gene in unilateral retinoblastoma cases from Tunisia and correlations with clinical features. PLoS One. 2015;10(1):e0116615. https://doi.org/10.1371/journal.pone.0116615

  11. Harbour JW. Molecular basis of low-penetrance retinoblastoma. Arch Ophthalmol. 2001;119(11):1699-704. https://doi.org/10.1001/archopht.119.11.1699

  12. Hung CC, Lin SY, Lee CN, Chen CP, Lin SP, Chao MC, et al. Low penetrance of retinoblastoma for p.V654L mutation of the RB1 gene. BMC Med Genet. 2011;12:76. https://doi.org/10.1186/1471-2350-12-76

  13. Mallipatna A, Marino M, Singh AD. Genetics of retinoblastoma. Asia Pac J Ophthalmol (Phila). 2016;5(4):260-4. https://doi.org/10.1097/APO.0000000000000219

  14. Temming P, Viehmann A, Biewald E, Lohmann DR. Sporadic unilateral retinoblastoma or first sign of bilateral disease? Br J Ophthalmol. 2013;97(4):475-80. https://doi.org/10.1136/bjophthalmol-2012-302666

  15. Tanti A. Estimate of mismatch repair deficient pancreatic cancer in patients enrolled in the Quebec pancreas cancer study [master's thesis]. [Montreal]: McGill University; 2019.

  16. Tomar S, Sethi R, Sundar G, Quah TC, Quah BL, Lai PS. Mutation spectrum of RB1 mutations in retinoblastoma cases from Singapore with implications for genetic management and counselling. PLoS One. 2017;12(6):e0178776. https://doi.org/10.1371/journal.pone.0178776

  17. Alonso J, García-Miguel P, Abelairas J, Mendiola M, Sarret E, Vendrell MT, et al. Spectrum of germline RB1 gene mutations in Spanish retinoblastoma patients: phenotypic and molecular epidemiological implications. Hum Mutat. 2001;17(5):412-22. https://doi.org/10.1002/humu.1117

  18. Kontic M, Palacios I, Gámez Á, Camino I, Latkovic Z, Rasic D, et al. New RB1 oncogenic mutations and intronic polymorphisms in Serbian retinoblastoma patients: genetic counseling implications. J Hum Genet. 2006;51(10):90-13. https://doi.org/10.1007/s10038-006-0036-y

  19. Macías M, Dean M, Atkinson A, Jiménez-Morales S, García-Vazquez FJ, Saldaña-Alvarez Y, et al. Spectrum of RB1 gene mutations and loss of heterozygosity in Mexican patients with retinoblastoma: identification of six novel mutations. Cancer Biomark. 2008;4(2):93-9. https://doi.org/10.3233/CBM-2008-4205

  20. Ali MJ, Parsam VL, Honavar SG, Kannabiran C, Vemuganti GK, Reddy VA. RB1 gene mutations in retinoblastoma and its clinical correlation. Saudi J Ophthalmol. 2010;24(4):119-23. https://doi.org/10.1016/j.sjopt.2010.05.003

  21. Barbosa RH, Aguiar FC, Silva MF, Costa RA, Vargas FR, Lucena E, et al. Screening of RB1 alterations in Brazilian patients with retinoblastoma and relatives with retinoma: phenotypic and genotypic associations. Invest Ophthalmol Vis Sci. 2013;54(5):3184-94. https://doi.org/10.1167/iovs.13-11686

  22. Parma D, Ferrer M, Luce L, Giliberto F, Szijan I. RB1 gene mutations in Argentine retinoblastoma patients. Implications for genetic counseling. PLoS One. 2017;12(12):e0189736. https://doi.org/10.1371/journal.pone.0189736

  23. Chow KN, Dean DC. Domains A and B in the Rb pocket interact to form a transcriptional repressor motif. Mol Cell Biol. 1996;16(9):4862-8. https://doi.org/10.1128/MCB.16.9.4862

  24. Hung A, Mager M, Hembury M, Stellacci F, Stevens MM, Yarovsky I. Amphiphilic amino acids: a key to adsorbing proteins to nanopatterned surfaces? Chem Sci. 2013;4(3):928-37. https://doi.org/10.1039/C2SC21639F

  25. Pánek J, Eidhammer I, Aasland R. A new method for identification of protein (sub)families in a set of proteins based on hydropathy distribution in proteins. Proteins. 2005;58(4):923-34. https://doi.org/10.1002/prot.20356

  26. Chen YL, Li QZ. Prediction of the subcellular location of apoptosis proteins. J Theor Biol. 2007;245(4):775-83. https://doi.org/10.1016/j.jtbi.2006.11.010

  27. Karp G. Cell and molecular biology: concepts and experiments. 6th ed. New York: John Wiley & Sons; 2010. Chapter 2, The chemical basis of life. p. 31-84.

  28. Razak MA, Begum PS, Viswanath B, Rajagopal S. Multifarious beneficial effect of nonessential amino acid, glycine: a review. Oxid Med Cell Longev. 2017;2017:1716701. https://doi.org/10.1155/2017/1716701

  29. Kaye FJ, Kratzke RA, Gerster JL, Horowitz JM. A single amino acid substitution results in a retinoblastoma protein defective in phosphorylation and oncoprotein binding. Proc Natl Acad Sci U S A. 1990;87(17):6922-6. https://doi.org/10.1073/pnas.87.17.6922

  30. Imperatore V, Pinto AM, Gelli E, Trevisson E, Morbidoni V, Frullanti E, et al. Parent-of-origin effect of hypomorphic pathogenic variants and somatic mosaicism impact on phenotypic expression of retinoblastoma. Eur J Hum Genet. 2018;26(7):1026-37. https://doi.org/10.1038/s41431-017-0054-6

  31. Gámez-Pozo A, Palacios I, Kontic M, Menéndez I, Camino I, García-Miguel P, et al. Pathogenic validation of unique germline intronic variants of RB1 in retinoblastoma patients using minigenes. Hum Mutat. 2007;28(12):1245. https://doi.org/10.1002/humu.9512

  32. Zhang K, Nowak I, Rushlow D, Gallie BL, Lohmann DR. Patterns of missplicing caused by RB1 gene mutations in patients with retinoblastoma and association with phenotypic expression. Hum Mutat. 2008;29(4):475-84. https://doi.org/10.1002/humu.20664

  33. Vaz-Drago R, Custódio N, Carmo-Fonseca M. Deep intronic mutations and human disease. Hum Genet. 2017;136(9):1093-111. https://doi.org/10.1007/s00439-017-1809-4

  34. Highsmith WE, Burch LH, Zhou Z, Olsen JC, Boat TE, Spock A, et al. A novel mutation in the cystic fibrosis gene in patients with pulmonary disease but normal sweat chloride concentrations. N Engl J Med. 1994;331(15):974-80. https://doi.org/10.1056/NEJM199410133311503

  35. McConville CM, Stankovic T, Byrd PJ, McGuire GM, Yao QY, Lennox GG, et al. Mutations associated with variant phenotypes in ataxia-telangiectasia. Am J Hum Genet. 1996;59(2):320-30.

  36. Stadhouders R, van den Heuvel A, Kolovos P, Jorna R, Leslie K, Grosveld F, et al. Transcription regulation by distal enhancers: who's in the loop? Transcription. 2012;3(4):181-6. https://doi.org/10.4161/trns.20720

  37. Char DH, Ellsworth R, Rabson AS, Albert DM, Herberman RB. Cell-mediated immunity to a retinoblastoma tissue culture line in patients with retinoblastoma. Am J Ophthalmol. 1974;78(1):5-11. https://doi.org/10.1016/0002-9394(74)90003-8

  38. Greger V, Passarge E, Höpping W, Messmer E, Horsthemke B. Epigenetic changes may contribute to the formation and spontaneous regression of retinoblastoma. Hum Genet. 1989;83(2):155-8. https://doi.org/10.1007/BF00286709

  39. Matsunaga E. Hereditary retinoblastoma: delayed mutation or host resistance? Am J Hum Genet. 1978;30(4):406-24.

  40. Bremner R, Du DC, Connolly-Wilson MJ, Bridge P, Ahmad KF, Mostachfi H, et al. Deletion of RB exons 24 and 25 causes low-penetrance retinoblastoma. Am J Hum Genet. 1997;61(3):556-70. https://doi.org/10.1086/515499

  41. Valverde JR, Alonso J, Palacios I, Pestaña A. RB1 gene mutation up-date, a meta-analysis based on 932 reported mutations available in a searchable database. BMC Genet. 2005;6:53. https://doi.org/10.1186/1471-2156-6-53

Published
2023-03-29
How to Cite
1.
Umar BT, Rimayanti U, Pagarra H, Budu, Massi N, Muhiddin HS. Novel point mutation and intronic mutations of <em>RB1</em&gt; gene in retinoblastoma patients in Indonesia. Med J Indones [Internet]. 2023Mar.29 [cited 2024Apr.18];31(4):218-24. Available from: http://mji.ui.ac.id/journal/index.php/mji/article/view/6544
Issue
Vol. 31 No. 4 (2022): December
Section
Basic Medical Research

Copyright (c) 2023 Batari Todja Umar, Ulfah Rimayanti, Halimah Pagarra, Budu, Nasrum Massi, Habibah Setyawati Muhiddin

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Authors who publish with Medical Journal of Indonesia agree to the following terms:

  1. Authors retain copyright and grant Medical Journal of Indonesia right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial License that allows others to remix, adapt, build upon the work non-commercially with an acknowledgment of the work’s authorship and initial publication in Medical Journal of Indonesia.
  2. Authors are permitted to copy and redistribute the journal's published version of the work non-commercially (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in Medical Journal of Indonesia.

Most read articles by the same author(s)